Article Details
Retrieved on: 2022-04-04 19:45:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Thus, the use of neutralizing monoclonal anti-SARS-CoV-2 antibody (MoAb) to confer a passive immunity appears attractive in KTRs. METHODS: We ...
Article found on: www.docwirenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here